首页 > 最新文献

Ayu最新文献

英文 中文
Efficacy of Sharapunkhadi powder (a polyherbal formulation) and lifestyle modification in the management of nonalcoholic fatty liver disease-A randomized placebo-controlled clinical trial. Sharapunkhadi散(一种多草药制剂)和生活方式改变在治疗非酒精性脂肪肝中的疗效——一项随机安慰剂对照临床试验
Ayu
Pub Date : 2020-04-01 Epub Date: 2021-10-23 DOI: 10.4103/ayu.AYU_281_19
E Remya, Mandip Goyal, Jitendra Varsakiya

Background: Nonalcoholic fatty liver disease (NAFLD) is an expanding health problem, which varies in prevalence among ethnic groups, occurring with an estimated global prevalence of 25%. In high-risk populations, the prevalence of NAFLD may be as high as 70%-90%. No established pharmacological treatment is available for NAFLD in modern medicine and hence, there is a search for alternative treatment modalities in other systems of medicine, which is safe and cost-effective.

Aim: The aim is to evaluate the efficacy of Sharapunkhadi powder and lifestyle modification in the management of NAFLD.

Materials and methods: Patients suffering from any of the components of metabolic syndrome, i.e. hypertension, diabetes mellitus, hypertriglyceridemia, elevated body mass index (>25 kg/m2), truncal obesity, or presenting with the symptoms of indigestion, abdominal discomfort, flatulence. were screened with liver function tests and ultrasonography (USG) of the abdomen. A total of 93 patients confirmed with fatty liver Grade 1-3 were selected for the present trial and were randomly divided into two groups. After Mridu Virechana (mild purgation) with Haritaki powder (6-8 g) according to Koshtha, in group A (n = 46), 2 capsules (500 mg each) filled with Sharapunkhadi powder thrice a day before food with warm water along with lifestyle modification were administered for 8 weeks. In group B (n = 47), capsules filled with roasted Sooji powder in the same dose as mentioned for group A was given along with lifestyle modification and were maintained as a placebo. Relief in subjective parameters such as indigestion, abdominal discomfort, and flatulence and improvement in the grades of fatty liver evident from USG was considered for the overall assessment of the therapy in both the groups. SigmaStat 3.1 software was used for statistical calculation. Wilcoxon signed-rank test for subjective criteria and Student's paired t-test for objective criteria were applied to check the level of significance in a single group before and after treatment, while Student's unpaired t-test for objective criteria was applied to assess the level of significance of difference observed between two groups.

Results: After 8 weeks of treatment, it was found from USG findings that there was a statistically significant improvement by about 39.25% in group A and 31.82% in group B, in the grade of fatty liver. The combination of Sharapunkhadi powder along with lifestyle modification provided comparatively better relief in subjective and objective parameters over the placebo control group.

Conclusion: Sharapunkhadi powder is a promising herbal preparation for the management of NAFLD and the combination of Sharapunkhadi powder along with lifestyle modification can yield more significant results in the management of NAFLD

背景:非酒精性脂肪性肝病(NAFLD)是一个不断扩大的健康问题,其患病率在不同种族群体中有所不同,估计全球患病率为25%。在高危人群中,NAFLD的患病率可高达70%-90%。现代医学没有针对NAFLD的既定药物治疗方法,因此,需要在其他医学系统中寻找安全且具有成本效益的替代治疗方式。目的:评价Sharapunkhadi散配合生活方式改变治疗NAFLD的疗效。材料和方法:患有代谢综合征任何组成部分的患者,如高血压、糖尿病、高甘油三酯血症、体重指数升高(>25 kg/m2)、躯干肥胖或有消化不良、腹部不适、胀气等症状的患者。通过肝功能检查和腹部超声检查(USG)进行筛查。本试验共选择93例确诊为1-3级脂肪肝的患者,随机分为两组。根据Koshtha的说法,在Mridu Virechana(轻度净化)与Haritaki粉(6-8 g)后,A组(n = 46),每天三次服用2粒胶囊(每粒500 mg),填充Sharapunkhadi粉,然后用温水喂食,同时改变生活方式,持续8周。在B组(n = 47)中,给予与A组相同剂量的烘烤Sooji粉胶囊,同时改变生活方式,并作为安慰剂维持。主观参数如消化不良、腹部不适和胀气的缓解以及USG中脂肪肝等级的改善被认为是对两组治疗的总体评估。采用SigmaStat 3.1软件进行统计计算。主观标准采用Wilcoxon sign -rank检验,客观标准采用Student’s配对t检验检验单组治疗前后的显著性水平,客观标准采用Student’s unpaired t检验评价两组间差异的显著性水平。结果:治疗8周后,USG结果显示,a组脂肪肝分级改善约39.25%,B组脂肪肝分级改善约31.82%,有统计学意义。与安慰剂对照组相比,Sharapunkhadi粉联合生活方式改变在主观和客观参数上提供了相对更好的缓解。结论:Sharapunkhadi散是治疗NAFLD的一种很有前途的中药制剂,Sharapunkhadi散联合生活方式改变治疗NAFLD的效果比单独改变生活方式更显著。
{"title":"Efficacy of <i>Sharapunkhadi</i> powder (a polyherbal formulation) and lifestyle modification in the management of nonalcoholic fatty liver disease-A randomized placebo-controlled clinical trial.","authors":"E Remya,&nbsp;Mandip Goyal,&nbsp;Jitendra Varsakiya","doi":"10.4103/ayu.AYU_281_19","DOIUrl":"https://doi.org/10.4103/ayu.AYU_281_19","url":null,"abstract":"<p><strong>Background: </strong>Nonalcoholic fatty liver disease (NAFLD) is an expanding health problem, which varies in prevalence among ethnic groups, occurring with an estimated global prevalence of 25%. In high-risk populations, the prevalence of NAFLD may be as high as 70%-90%. No established pharmacological treatment is available for NAFLD in modern medicine and hence, there is a search for alternative treatment modalities in other systems of medicine, which is safe and cost-effective.</p><p><strong>Aim: </strong>The aim is to evaluate the efficacy of <i>Sharapunkhadi</i> powder and lifestyle modification in the management of NAFLD.</p><p><strong>Materials and methods: </strong>Patients suffering from any of the components of metabolic syndrome, i.e. hypertension, diabetes mellitus, hypertriglyceridemia, elevated body mass index (>25 kg/m<sup>2</sup>), truncal obesity, or presenting with the symptoms of indigestion, abdominal discomfort, flatulence. were screened with liver function tests and ultrasonography (USG) of the abdomen. A total of 93 patients confirmed with fatty liver Grade 1-3 were selected for the present trial and were randomly divided into two groups. After <i>Mridu Virechana</i> (mild purgation) with <i>Haritaki</i> powder (6-8 g) according to Koshtha, in group A (n = 46), 2 capsules (500 mg each) filled with <i>Sharapunkhadi</i> powder thrice a day before food with warm water along with lifestyle modification were administered for 8 weeks. In group B (n = 47), capsules filled with roasted Sooji powder in the same dose as mentioned for group A was given along with lifestyle modification and were maintained as a placebo. Relief in subjective parameters such as indigestion, abdominal discomfort, and flatulence and improvement in the grades of fatty liver evident from USG was considered for the overall assessment of the therapy in both the groups. SigmaStat 3.1 software was used for statistical calculation. Wilcoxon signed-rank test for subjective criteria and Student's paired <i>t</i>-test for objective criteria were applied to check the level of significance in a single group before and after treatment, while Student's unpaired <i>t</i>-test for objective criteria was applied to assess the level of significance of difference observed between two groups.</p><p><strong>Results: </strong>After 8 weeks of treatment, it was found from USG findings that there was a statistically significant improvement by about 39.25% in group A and 31.82% in group B, in the grade of fatty liver. The combination of <i>Sharapunkhadi</i> powder along with lifestyle modification provided comparatively better relief in subjective and objective parameters over the placebo control group.</p><p><strong>Conclusion: </strong><i>Sharapunkhadi</i> powder is a promising herbal preparation for the management of NAFLD and the combination of <i>Sharapunkhadi</i> powder along with lifestyle modification can yield more significant results in the management of NAFLD","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/93/d4/AYU-41-98.PMC8614208.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39839023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Pharmacodynamic interaction of Tinospora cordifolia Willd. With Ocimum sanctum Linn. in isoproterenol-induced cardiac toxicity. 堇叶Tinospora cordifolia Willd的药效学相互作用。和至圣林一起。异丙肾上腺素引起的心脏毒性。
Ayu
Pub Date : 2020-04-01 Epub Date: 2021-10-23 DOI: 10.4103/ayu.AYU_127_19
Chetan Savant, V H Kulkarni, P V Habbu, Preeti V Kulkarni, Muhammed Majeed, Mahadeva Nayak

Background: Cardiovascular diseases are the leading causes of deaths despite several advancements in the current medical interventions. Among them, myocardial infarction (MI) is the most alarming disease as about 17.1 million peoples die every year due to MI.

Aim: The present study was designed to investigate the potential cardioprotective effect of combination of standardized extracts of Tinospora cordifolia (SETC) (250 mg/kg and 500 mg/kg) and Ocimum sanctum (SEOS) (50 mg/kg) in isoproterenol (ISO)-induced MI.

Materials and methods: MI was induced in rats by subcutaneous injection of ISO for 2 consecutive days at an interval of 24 h. Rats were pretreated with test drugs for the period of 21 days, and ISO was administered on the 20th and 21st days. At the end of experiment, i.e., on 22nd-day electrocardiograph, a hemodynamic, biochemical, and histopathological study of heart tissues was evaluated from control and experimental groups and statistically analyzed by one-way analysis of variance followed by Tukey's test.

Results: ISO-administered rats showed significant changes in electrocardiograph, mean arterial blood pressure, heart rate, biochemical markers, antioxidant parameters, and histopathology of heart. The activities of cardiac biomarkers were reduced in serum, and there was an increase in antioxidants in heart tissue of test drug-treated animals. Similarly, electrocardiograph, mean arterial blood pressure, and heart rate were restored to normalcy in all test and standard drug-treated animals.

Conclusion: The SETC 500 mg/kg in combination with SEOS 50 mg/kg was found to be effective in prevention of myocardial injury induced by ISO.

背景:尽管目前的医疗干预措施取得了一些进展,但心血管疾病仍是导致死亡的主要原因。其中,心肌梗死(MI)是最令人担忧的疾病,每年约有1710万人因心肌梗死而死亡。目的:探讨异丙肾上腺素(ISO)诱导的心肌梗死中,Tinospora cordifolia (SETC) (250 mg/kg和500 mg/kg)和Ocimum sanctum (SEOS) (50 mg/kg)联合使用的潜在心脏保护作用。采用连续2天皮下注射ISO诱导大鼠心肌梗死,间隔24 h,给药21天,第20、21天给药ISO。实验结束即第22天心电图时,分别对对照组和实验组进行心脏组织血流动力学、生化和组织病理学研究,采用单因素方差分析及Tukey检验进行统计学分析。结果:给药大鼠心电图、平均动脉血压、心率、生化指标、抗氧化指标及心脏组织病理学均有显著变化。实验动物血清中心脏生物标志物活性降低,心脏组织中抗氧化剂含量增加。同样,所有试验动物和标准药物治疗动物的心电图、平均动脉血压和心率均恢复正常。结论:SETC 500 mg/kg联合SEOS 50 mg/kg可有效预防ISO所致心肌损伤。
{"title":"Pharmacodynamic interaction of <i>Tinospora cordifolia</i> Willd. With <i>Ocimum sanctum</i> Linn. in isoproterenol-induced cardiac toxicity.","authors":"Chetan Savant,&nbsp;V H Kulkarni,&nbsp;P V Habbu,&nbsp;Preeti V Kulkarni,&nbsp;Muhammed Majeed,&nbsp;Mahadeva Nayak","doi":"10.4103/ayu.AYU_127_19","DOIUrl":"https://doi.org/10.4103/ayu.AYU_127_19","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular diseases are the leading causes of deaths despite several advancements in the current medical interventions. Among them, myocardial infarction (MI) is the most alarming disease as about 17.1 million peoples die every year due to MI.</p><p><strong>Aim: </strong>The present study was designed to investigate the potential cardioprotective effect of combination of standardized extracts of <i>Tinospora cordifolia</i> (SETC) (250 mg/kg and 500 mg/kg) and <i>Ocimum sanctum</i> (SEOS) (50 mg/kg) in isoproterenol (ISO)-induced MI.</p><p><strong>Materials and methods: </strong>MI was induced in rats by subcutaneous injection of ISO for 2 consecutive days at an interval of 24 h. Rats were pretreated with test drugs for the period of 21 days, and ISO was administered on the 20<sup>th</sup> and 21<sup>st</sup> days. At the end of experiment, i.e., on 22<sup>nd</sup>-day electrocardiograph, a hemodynamic, biochemical, and histopathological study of heart tissues was evaluated from control and experimental groups and statistically analyzed by one-way analysis of variance followed by Tukey's test.</p><p><strong>Results: </strong>ISO-administered rats showed significant changes in electrocardiograph, mean arterial blood pressure, heart rate, biochemical markers, antioxidant parameters, and histopathology of heart. The activities of cardiac biomarkers were reduced in serum, and there was an increase in antioxidants in heart tissue of test drug-treated animals. Similarly, electrocardiograph, mean arterial blood pressure, and heart rate were restored to normalcy in all test and standard drug-treated animals.</p><p><strong>Conclusion: </strong>The SETC 500 mg/kg in combination with SEOS 50 mg/kg was found to be effective in prevention of myocardial injury induced by ISO.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/df/f8/AYU-41-130.PMC8614206.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39726024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevention of in vitro glucose-induced cataract by Vasanjana prepared by Yashtimadhu Kalka (paste of Glycyrrhyza glabra Linn). 甘草浆制备的水参水对体外葡萄糖性白内障的预防作用。
Ayu
Pub Date : 2020-04-01 Epub Date: 2021-10-23 DOI: 10.4103/ayu.AYU_99_20
Manjusha Rajagopala, B Ravishankar, B K Ashok, B Gupta Varun

Background: Cataract is a major cause of blindness worldwide. Researchers received much attention from the traditional systems such as Ayurveda for the solutions of cataract through antioxidant activities apart from the surgical extraction.

Aims: A To study, the anti-cataract activity of Vasanjana (VK) prepared with Yashtimadhu (Glycyrrhyza glabra Linn) Kalka (paste) in Vasa (fat) of the domestic fowl (Gallus gallus) on glucose-induced cataract in ovine (sheep) lenses.

Materials and methods: Artificial aqueous humor with 55 mM glucose was used to induce cataract in sheep eye lenses. Treatment was given with cow ghee (CG), plain fat, Vasanjana, and Vitamin E to the same media and lenses were incubated at the room temperature for 72 h. Biochemical parameters studied in the lens were total proteins, malondialdehyde (MDA), Na+ K+ ATPase activity and electrolytes (Na+ and K+). Photographic evaluation was also done.

Results: The complete opacification induced by the glucose in ovine lens was observed in 72 h. Cataractous lenses showed significant increase in Na+, MDA level and significant decrease in Na+ K+ ATPase activity and total protein content. Lenses treated with Vasanjana showed non-significant increase of total protein content and decreased MDA level and prevented formation and progress of cataract by glucose, as evidenced by photographic evaluation. Glucose-induced biochemical changes were found to be reversed in statistically significant manner in CG and Vitamin E treated lenses.

Conclusion: The anti-cataract activity of Vasanjana and CG may be because of the antioxidant and free radical scavenging activity. Further in vitro and in vivo studies in various experimental models are required to validate their anti-cataract activity.

背景:白内障是全世界失明的主要原因。传统医学如阿育吠陀,除了通过手术摘除白内障外,还通过抗氧化活性来解决白内障的问题,受到了研究人员的广泛关注。目的:研究在家禽(Gallus Gallus)的Vasa(脂肪)中加入Yashtimadhu (Glycyrrhyza glabra Linn) Kalka(膏体)制备的Vasanjana (VK)对羊(羊)晶状体葡萄糖性白内障的抗白内障活性。材料和方法:采用含55 mM葡萄糖的人工房水诱导羊眼晶状体白内障。将牛油(CG)、普通脂肪、Vasanjana和维生素E添加到相同的培养基中,在室温下培养72 h。研究晶状体的生化参数为总蛋白、丙二醛(MDA)、Na+ K+ atp酶活性和电解质(Na+和K+)。还进行了摄影评价。结果:葡萄糖作用72 h使羊晶状体完全混浊,晶状体内Na+、MDA水平显著升高,Na+ K+ atp酶活性和总蛋白含量显著降低。照片评价表明,Vasanjana处理晶状体后,总蛋白含量无明显增加,MDA水平降低,葡萄糖抑制白内障的形成和进展。葡萄糖诱导的生化变化在CG和维生素E处理的晶状体中有统计学意义的逆转。结论:黄芪和黄芪具有抗白内障作用可能与黄芪的抗氧化和自由基清除作用有关。进一步的体外和体内研究需要在各种实验模型中验证其抗白内障活性。
{"title":"Prevention of <i>in vitro</i> glucose-induced cataract by <i>Vasanjana</i> prepared by <i>Yashtimadhu Kalka</i> (paste of <i>Glycyrrhyza glabra</i> Linn).","authors":"Manjusha Rajagopala,&nbsp;B Ravishankar,&nbsp;B K Ashok,&nbsp;B Gupta Varun","doi":"10.4103/ayu.AYU_99_20","DOIUrl":"https://doi.org/10.4103/ayu.AYU_99_20","url":null,"abstract":"<p><strong>Background: </strong>Cataract is a major cause of blindness worldwide. Researchers received much attention from the traditional systems such as Ayurveda for the solutions of cataract through antioxidant activities apart from the surgical extraction.</p><p><strong>Aims: </strong>A To study, the anti-cataract activity of <i>Vasanjana</i> (VK) prepared with <i>Yashtimadhu</i> (<i>Glycyrrhyza glabra</i> Linn) <i>Kalka</i> (paste) in <i>Vasa</i> (fat) of the domestic fowl (<i>Gallus gallus</i>) on glucose-induced cataract in ovine (sheep) lenses.</p><p><strong>Materials and methods: </strong>Artificial aqueous humor with 55 mM glucose was used to induce cataract in sheep eye lenses. Treatment was given with cow ghee (CG), plain fat, <i>Vasanjana</i>, and Vitamin E to the same media and lenses were incubated at the room temperature for 72 h. Biochemical parameters studied in the lens were total proteins, malondialdehyde (MDA), Na<sup>+</sup> K<sup>+</sup> ATPase activity and electrolytes (Na<sup>+</sup> and K<sup>+</sup>). Photographic evaluation was also done.</p><p><strong>Results: </strong>The complete opacification induced by the glucose in ovine lens was observed in 72 h. Cataractous lenses showed significant increase in Na<sup>+</sup>, MDA level and significant decrease in Na<sup>+</sup> K<sup>+</sup> ATPase activity and total protein content. Lenses treated with <i>Vasanjana</i> showed non-significant increase of total protein content and decreased MDA level and prevented formation and progress of cataract by glucose, as evidenced by photographic evaluation. Glucose-induced biochemical changes were found to be reversed in statistically significant manner in CG and Vitamin E treated lenses.</p><p><strong>Conclusion: </strong>The anti-cataract activity of <i>Vasanjana</i> and CG may be because of the antioxidant and free radical scavenging activity. Further <i>in vitro</i> and <i>in vivo</i> studies in various experimental models are required to validate their anti-cataract activity.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ad/62/AYU-41-136.PMC8614204.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39726025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Need to safeguard insensible wastage of Ayurvedic medicines. 需要保护阿育吠陀药物的无谓浪费。
Ayu
Pub Date : 2020-01-01 Epub Date: 2021-07-30 DOI: 10.4103/ayu.AYU_56_20
Mahesh Kumar, Jitendra N Varsakiya
On keen observation in the routine clinical practices, it introduce that there are diverse sources of drug wastage from the manufacturer to consumer’s level. The community usually thinks that the drugs are available abundantly in the market and thus is not challenging, but that is not true. In the era of progressive urbanization, deforestation and lesser interest in the cultivation of medicinal plants are the matter of apprehension which leads to limited resources. Furthermore, drug wastage ultimately affects the economy of the nation. Although the complete reduction the total drug wastage is not an easy task, but awareness regarding insensible wastage can help for inculcating the habit of sensible use of medicines. For this purpose, awareness regarding importance of herbs, its limited resources can help to stop insensible drug wastage and to save the drug, for the future use will add value to patient care and reduce burden of health care system.
{"title":"Need to safeguard insensible wastage of Ayurvedic medicines.","authors":"Mahesh Kumar,&nbsp;Jitendra N Varsakiya","doi":"10.4103/ayu.AYU_56_20","DOIUrl":"https://doi.org/10.4103/ayu.AYU_56_20","url":null,"abstract":"On keen observation in the routine clinical practices, it introduce that there are diverse sources of drug wastage from the manufacturer to consumer’s level. The community usually thinks that the drugs are available abundantly in the market and thus is not challenging, but that is not true. In the era of progressive urbanization, deforestation and lesser interest in the cultivation of medicinal plants are the matter of apprehension which leads to limited resources. Furthermore, drug wastage ultimately affects the economy of the nation. Although the complete reduction the total drug wastage is not an easy task, but awareness regarding insensible wastage can help for inculcating the habit of sensible use of medicines. For this purpose, awareness regarding importance of herbs, its limited resources can help to stop insensible drug wastage and to save the drug, for the future use will add value to patient care and reduce burden of health care system.","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/34/73/AYU-41-66.PMC8415234.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39452941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of health-care services for older population in India and possibility of incorporating AYUSH in public health system for geriatric care. 审查印度老年人口的卫生保健服务和将AYUSH纳入公共卫生系统的老年保健的可能性。
Ayu
Pub Date : 2020-01-01 Epub Date: 2021-07-30 DOI: 10.4103/ayu.AYU_172_16
Pallavi Suresh Mundada, Sakshi Sharma, Bharti Gupta, M M Padhi, Aparajit B Dey, K S Dhiman

Background: In a developing country like India, which has 10.11% population of >60 years age and a projection of rise of the same by 300% in 2050, health care of elderly is an enormous challenge. The developed world has evolved many models for elderly care, for example, nursing home care, health insurance, etc. Indian Government has also taken multiple measures in this direction by initiating National Policy on Older Persons, 1999, the Maintenance and Welfare of Parents and Senior Citizens Act, 2007, the Old Age Pension Scheme, Rashtriya Vayoshri Yojana 2017, etc. However, there is a necessity that, India must rapidly adapt to the complex health related, social and economic challenges caused by these demographic changes. This may be an opportunity for innovation in the health system by developing a perspective for healthy and active aging, though it is a major challenge. Health care of the older people cannot be achieved unless total health, i.e., physical, social, economic, psychological, and spiritual aspects are addressed.

Objective: The objective is to study current policies regarding geriatric health care in India and to propose the possibility to develop a model to provide comprehensive and dedicated health-care services to the older population by integrating conventional and indigenous systems of medicine dwelling in the country.

Materials and methods: Electronic search in various scientific journals for research and review articles; electronic along with hand searching of conference proceedings, brochures, government policy documents, press releases, Ayurveda classical texts, etc., regarding geriatric health care in India and model health-care facilities in other countries and regarding of AYUSH systems in geriatric health care in India.

Results: There is an urgent need of adaptation and modification in the National Health System to cater the actual requirements of the elderly with plans and strategies dedicated to face their health-related challenges. Adoption of inclusive health-care interventions, can improve health outcomes by making it more acceptable, accessible, and affordable.

Conclusion: Integration of AYUSH at various levels of health-care delivery system can potentially contribute to provide unique newer dimensions to the field of geriatric care in India.

背景:在印度这样的发展中国家,60岁以上的人口占10.11%,预计到2050年将增长300%,老年人的医疗保健是一个巨大的挑战。发达国家已经发展出许多老年人护理模式,例如养老院护理、健康保险等。印度政府也在这方面采取了多项措施,包括1999年的《国家老年人政策》、2007年的《父母和老年人赡养和福利法》、2017年的《老年养老金计划》等。然而,印度必须迅速适应这些人口变化所造成的复杂的与健康有关的社会和经济挑战。这可能是卫生系统创新的一个机会,通过发展健康和积极老龄化的观点,尽管这是一个重大挑战。除非全面解决健康问题,即身体、社会、经济、心理和精神方面的问题,否则无法实现老年人的保健。目标:目标是研究印度目前有关老年保健的政策,并提出是否有可能制定一种模式,通过整合该国的传统和土著医学系统,向老年人口提供全面和专门的保健服务。材料和方法:电子检索各类科学期刊的研究和评论文章;电子和手动搜索会议记录,小册子,政府政策文件,新闻稿,阿育吠陀经典文本等,关于印度的老年医疗保健和其他国家的示范医疗保健设施,以及关于印度老年医疗保健的AYUSH系统。结果:国家卫生系统迫切需要适应和修改,以满足老年人的实际需求,制定计划和策略,致力于应对老年人的健康挑战。采用包容性卫生保健干预措施可以改善健康结果,使其更容易被接受、获得和负担得起。结论:在各级卫生保健提供系统中整合AYUSH可能有助于为印度老年保健领域提供独特的更新维度。
{"title":"Review of health-care services for older population in India and possibility of incorporating AYUSH in public health system for geriatric care.","authors":"Pallavi Suresh Mundada,&nbsp;Sakshi Sharma,&nbsp;Bharti Gupta,&nbsp;M M Padhi,&nbsp;Aparajit B Dey,&nbsp;K S Dhiman","doi":"10.4103/ayu.AYU_172_16","DOIUrl":"https://doi.org/10.4103/ayu.AYU_172_16","url":null,"abstract":"<p><strong>Background: </strong>In a developing country like India, which has 10.11% population of >60 years age and a projection of rise of the same by 300% in 2050, health care of elderly is an enormous challenge. The developed world has evolved many models for elderly care, for example, nursing home care, health insurance, etc. Indian Government has also taken multiple measures in this direction by initiating National Policy on Older Persons, 1999, the Maintenance and Welfare of Parents and Senior Citizens Act, 2007, the Old Age Pension Scheme, Rashtriya Vayoshri Yojana 2017, etc. However, there is a necessity that, India must rapidly adapt to the complex health related, social and economic challenges caused by these demographic changes. This may be an opportunity for innovation in the health system by developing a perspective for healthy and active aging, though it is a major challenge. Health care of the older people cannot be achieved unless total health, i.e., physical, social, economic, psychological, and spiritual aspects are addressed.</p><p><strong>Objective: </strong>The objective is to study current policies regarding geriatric health care in India and to propose the possibility to develop a model to provide comprehensive and dedicated health-care services to the older population by integrating conventional and indigenous systems of medicine dwelling in the country.</p><p><strong>Materials and methods: </strong>Electronic search in various scientific journals for research and review articles; electronic along with hand searching of conference proceedings, brochures, government policy documents, press releases, Ayurveda classical texts, etc., regarding geriatric health care in India and model health-care facilities in other countries and regarding of AYUSH systems in geriatric health care in India.</p><p><strong>Results: </strong>There is an urgent need of adaptation and modification in the National Health System to cater the actual requirements of the elderly with plans and strategies dedicated to face their health-related challenges. Adoption of inclusive health-care interventions, can improve health outcomes by making it more acceptable, accessible, and affordable.</p><p><strong>Conclusion: </strong>Integration of AYUSH at various levels of health-care delivery system can potentially contribute to provide unique newer dimensions to the field of geriatric care in India.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/85/e5/AYU-41-3.PMC8415232.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39450949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shodhana (processing) of Rakta-Snuhi (Euphorbia caducifolia Haines.) latex with Chincha (Tamarindus indica L.) leaf juice: A pharmaceutical analysis. 与柽柳(Tamarindus indica L.)叶汁的Rakta-Snuhi (Euphorbia caducifolia Haines.)乳胶的加工:药物分析。
Ayu
Pub Date : 2020-01-01 Epub Date: 2021-07-30 DOI: 10.4103/ayu.AYU_90_17
Shashi Gupta, Rabinarayan Acharya, Vinay J Shukla

Background: Latex of Euphorbia caducifolia Haines. (Euphorbiaceae), botanical source of Rakta Snuhi, a caustic irritant, is being used in different Ayurvedic therapeutics, after proper processing (Shodhana) in some specific media. Shodhana of Snuhi latex with Chincha-Patra Swarasa (juice of tamarind leaves) using Raudra Yantra (instrument/pot kept under sunlight for drying) has been recommended in Ayurveda texts. Snuhi is one of the Upavisha (sub toxic group of herbal drugs) and a well-known plant in the Indian system of medicine. It is used in pharmaceutical procedures like preparation and processing of drugs.

Aim: The aim of the study was to carry out Shodhana of E. caducifolia latex with Chincha-Patra Swarasa.

Material and methods: Fresh latex of Snuhi was collected from the Sapada area of Jamnagar, Gujarat and fresh leaves of Tamarindus indica L. were collected from the herbal garden of the university and Swarasa was extracted by traditional expression technique. Shodhana of Snuhi Kshira was done under sunlight dried and shade dried method by mixing it with leaf juice of Tamarindus indica L. in a glass bowl in different ratio i.e. Kshira: leaf juice was 8:4, 8:2, 8:1 respectively.

Results: This study reveals certain changes in physico-chemical parameters (pH) and organoleptic characters of processed E. caducifolia latex by Tamarind leaf juice both in shade-dried and sunlight-dried samples. Under HPTLC, Shodhana of E. caducifolia latex with Tamarind leaf juice alters the number of spots both sunlight-dried and shade-dried samples. In sun-dried sample, the number of spots increased when the concentration of Tamarind leaf juice is decreased in HPTLC study. The study reveals that in case of shade-dried Shodhita (processed) Snuhi latex sample, the concentration of lupeol increases with the increasing quantity of Tamarind leaf juice.

Conclusion: Shodhana with Tamarind leaf juice changes both qualitative and quantitative property of Snuhi latex.

背景:大戟(Euphorbia caducifolia Haines)乳胶。(大戟科),一种腐蚀性刺激物Rakta Snuhi的植物来源,在某些特定介质中经过适当处理(Shodhana)后,被用于不同的阿育吠陀疗法。在阿育吠陀文献中推荐使用Raudra Yantra(在阳光下保持干燥的仪器/锅)将Snuhi乳胶与Chincha-Patra Swarasa(罗罗子叶汁)一起使用。Snuhi是Upavisha(亚毒性草药组)之一,也是印度医学系统中著名的植物。它用于药物的制备和加工等制药过程。目的:研究用金针叶-白桦花对白针叶胶乳的抑菌作用。材料与方法:采自古吉拉特邦贾姆纳格尔萨帕达地区的新鲜Snuhi乳胶,采自该大学植物园内的柽柳树(Tamarindus indica L.)新鲜叶片,采用传统表达技术提取Swarasa。将Snuhi Kshira与柽柳叶汁分别以8:4、8:2、8:1的比例混合在玻璃碗中,采用日光干燥法和阴干法进行Shodhana。结果:本研究揭示了罗望子叶汁在遮荫干燥和日光干燥两种条件下,加工后的酸枝叶乳的理化参数(pH)和感官特性发生了一定的变化。在HPTLC下,与罗望子叶汁混合的酸枝叶乳改变了日光干燥和遮荫干燥样品的斑点数。在晒干后的样品中,随着罗望子叶汁浓度的降低,斑点数量增加。研究表明,在遮晒的情况下,随着罗望子叶汁用量的增加,鲁皮醇的浓度也随之增加。结论:加罗望子叶汁可改变南喜胶乳的定性和定量性质。
{"title":"<i>Shodhana</i> (processing) of <i>Rakta-Snuhi</i> (<i>Euphorbia caducifolia Haines</i>.) latex with <i>Chincha</i> (<i>Tamarindus indica</i> L.) leaf juice: A pharmaceutical analysis.","authors":"Shashi Gupta,&nbsp;Rabinarayan Acharya,&nbsp;Vinay J Shukla","doi":"10.4103/ayu.AYU_90_17","DOIUrl":"https://doi.org/10.4103/ayu.AYU_90_17","url":null,"abstract":"<p><strong>Background: </strong>Latex of <i>Euphorbia</i> <i>caducifolia</i> Haines. (Euphorbiaceae), botanical source of <i>Rakta</i> <i>Snuhi</i>, a caustic irritant, is being used in different Ayurvedic therapeutics, after proper processing (<i>Shodhana</i>) in some specific media. <i>Shodhana</i> of <i>Snuhi</i> latex with <i>Chincha-Patra</i> <i>Swarasa</i> (juice of tamarind leaves) using <i>Raudra</i> <i>Yantra</i> (instrument/pot kept under sunlight for drying) has been recommended in Ayurveda texts. <i>Snuhi</i> is one of the <i>Upavisha</i> (sub toxic group of herbal drugs) and a well-known plant in the Indian system of medicine. It is used in pharmaceutical procedures like preparation and processing of drugs.</p><p><strong>Aim: </strong>The aim of the study was to carry out <i>Shodhana</i> of <i>E. caducifolia</i> latex with <i>Chincha-Patra</i> <i>Swarasa</i>.</p><p><strong>Material and methods: </strong>Fresh latex of <i>Snuhi</i> was collected from the Sapada area of Jamnagar, Gujarat and fresh leaves of <i>Tamarindus indica</i> L. were collected from the herbal garden of the university and <i>Swarasa</i> was extracted by traditional expression technique. <i>Shodhana</i> of <i>Snuhi Kshira</i> was done under sunlight dried and shade dried method by mixing it with leaf juice of <i>Tamarindus indica</i> L. in a glass bowl in different ratio i.e. <i>Kshira</i>: leaf juice was 8:4, 8:2, 8:1 respectively.</p><p><strong>Results: </strong>This study reveals certain changes in physico-chemical parameters (pH) and organoleptic characters of processed <i>E. caducifolia</i> latex by <i>Tamarind</i> leaf juice both in shade-dried and sunlight-dried samples. Under HPTLC, <i>Shodhana</i> of <i>E. caducifolia</i> latex with <i>Tamarind</i> leaf juice alters the number of spots both sunlight-dried and shade-dried samples. In sun-dried sample, the number of spots increased when the concentration of <i>Tamarind</i> leaf juice is decreased in HPTLC study. The study reveals that in case of shade-dried <i>Shodhita</i> (processed) <i>Snuhi</i> latex sample, the concentration of lupeol increases with the increasing quantity of <i>Tamarind</i> leaf juice.</p><p><strong>Conclusion: </strong><i>Shodhana</i> with <i>Tamarind</i> leaf juice changes both qualitative and quantitative property of <i>Snuhi</i> latex.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f9/b4/AYU-41-24.PMC8415233.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39473809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding the etiopathogenesis and diagnosis of malignancy in the framework of Ayurveda: A review based on experience of working in an institute of oncology. 了解阿育吠陀框架下恶性肿瘤的发病和诊断:基于肿瘤研究所工作经验的回顾。
Ayu
Pub Date : 2020-01-01 Epub Date: 2021-07-30 DOI: 10.4103/ayu.AYU_45_18
B V Kumaraswamy

Background: The etiopathogenesis and diagnosis of cancer has intrigued modern oncology researchers for decades, and it is still a rapidly growing area in medicine. Cancer is not a single disease, but rather a collection of related diseases which is diagnosed on the basis of aberrant cellular changes. Since this is established by the modern medical science, it becomes important to understand it from the perspective of Ayurveda. Despite the fact that there are a few endeavors in this area, there is no common agreement among the experts. The current article is an effort to fulfill this knowledge gap.

Aims and objectives: To understand the cancer systematically in the frame work of Ayurveda and propose its probable Samprapti (pathogenic process) based on clinical observations.

Materials and methods: It is based on the clinical observation and detailed examination of 400 cancer patients, following modern and Ayurvedic methods in an institution dedicated to oncology.

Results: After careful study of each type of cases of cancer at its all stages to understand the natural history and clinical behavior, Ayurvedic pathogenesis, diagnosis with possible etiologic association has been arrived at. Three main conditions, namely Udara (enlargement of abdomen), Gulma (lump in abdomen) and Vidradhi (abscess) can be equated with cancer.

Conclusion: Modern diagnosis of cancer cannot be equated with any single disease entity mentioned in the Ayurvedic literature. Udara-Gulma-Vidradhi is the abdominal tumors present as benign and possess cancerous potential.

背景:几十年来,癌症的发病机制和诊断一直吸引着现代肿瘤学研究人员的兴趣,它仍然是医学上一个快速发展的领域。癌症不是一种单一的疾病,而是根据细胞的异常变化来诊断的一系列相关疾病的集合。由于这是由现代医学建立的,从阿育吠陀的角度来理解它变得很重要。尽管在这一领域有一些努力,但专家之间没有达成共识。本文将努力填补这一知识空白。目的:在阿育吠陀医学框架下系统认识癌症,并根据临床观察提出其可能的Samprapti(致病过程)。材料和方法:它是基于对400名癌症患者的临床观察和详细检查,遵循现代和阿育吠陀的方法,在一个专门的肿瘤机构。结果:通过对每一类型的癌症病例在其各个阶段的仔细研究,了解其自然史和临床行为、阿育吠陀的发病机制、诊断和可能的病因学关联。三种主要情况,即Udara(腹部肿大),Gulma(腹部肿块)和Vidradhi(脓肿)可以等同于癌症。结论:现代癌症的诊断不能等同于任何单一的疾病实体在阿育吠陀文献中提到。Udara-Gulma-Vidradhi是一种腹部肿瘤,表现为良性,具有癌变潜力。
{"title":"Understanding the etiopathogenesis and diagnosis of malignancy in the framework of <i>Ayurveda</i>: A review based on experience of working in an institute of oncology.","authors":"B V Kumaraswamy","doi":"10.4103/ayu.AYU_45_18","DOIUrl":"https://doi.org/10.4103/ayu.AYU_45_18","url":null,"abstract":"<p><strong>Background: </strong>The etiopathogenesis and diagnosis of cancer has intrigued modern oncology researchers for decades, and it is still a rapidly growing area in medicine. Cancer is not a single disease, but rather a collection of related diseases which is diagnosed on the basis of aberrant cellular changes. Since this is established by the modern medical science, it becomes important to understand it from the perspective of <i>Ayurveda</i>. Despite the fact that there are a few endeavors in this area, there is no common agreement among the experts. The current article is an effort to fulfill this knowledge gap.</p><p><strong>Aims and objectives: </strong>To understand the cancer systematically in the frame work of Ayurveda and propose its probable <i>Samprapti</i> (pathogenic process) based on clinical observations.</p><p><strong>Materials and methods: </strong>It is based on the clinical observation and detailed examination of 400 cancer patients, following modern and Ayurvedic methods in an institution dedicated to oncology.</p><p><strong>Results: </strong>After careful study of each type of cases of cancer at its all stages to understand the natural history and clinical behavior, Ayurvedic pathogenesis, diagnosis with possible etiologic association has been arrived at. Three main conditions, namely <i>Udara</i> (enlargement of abdomen), <i>Gulma</i> (lump in abdomen) and <i>Vidradhi</i> (abscess) can be equated with cancer.</p><p><strong>Conclusion: </strong>Modern diagnosis of cancer cannot be equated with any single disease entity mentioned in the Ayurvedic literature. <i>Udara-Gulma-Vidradhi</i> is the abdominal tumors present as benign and possess cancerous potential.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/35/47/AYU-41-58.PMC8415240.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39452942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Chronic toxicity study of Sameera Pannaga Rasa in Charle's foster albino rats. 白化大鼠慢性毒性研究。
Ayu
Pub Date : 2020-01-01 Epub Date: 2021-07-30 DOI: 10.4103/ayu.AYU_49_20
Madhvi Sharma, Biswajyoti Patgiri, Mukesh B Nariya, Shrirang Jamadagni, Prashant Bedarkar

Introduction: Sameera Pannaga Rasa (SPR) is a Kupi Pakwa Rasayana (a mercurial-arsenical formulation of Ayurveda prepared by specific pharmaceutical-controlled, indirect heat treatment [sand bath] in glass bottle) that contains Shodhita Parada (processed mercury), Shodhita Gandhaka (processed sulfur), Shodhita Haratala (processed arsenic trisulfide), Shodhita Somala (processed arsenic oxide) and Shodhita Manahshila (process arsenic disulfide) in equal quantity as ingredients. Parada, Haratala, Manahshila and Somala are highly potent minerals which are included in the Drug and Cosmetic Act 1940 under Schedule E1 because of their toxic nature in crude form.

Materials and methods: In the present study, SPR was evaluated for safety profile through its chronic toxicity study in Charle's foster albino rats. The test drug was made into suspension in vehicle (4 ml honey and 7 ml distilled water). The test drug was administered orally once a day for 90 consecutive days in the dose of 11.25 (therapeutic dose [TED]), 56.25 (5 times TED) and 112.25 mg/kg (10 times TED). Animals were sacrificed on 91st day and animals of recovery group were sacrificed on 121st day. Parameters such as hematological, serum biochemical, and histopathology of various organs were studied.

Results: Test drug at a higher dose level and recovery study showed no toxic effect in albino rats during chronic toxicity study.

Conclusion: SPR is found to have no toxic effect in albino rats during the repeated dose, oral, chronic toxicity study of 90 days, even at 10 times therapeutic equivalent dose (112.25 mg/kg) and even during recovery period of 1 month. It may be safety used at TED level.

简介:Sameera Pannaga Rasa (SPR)是一种Kupi Pakwa Rasayana(一种阿育陀汞砷配方,通过特定的药物控制,间接热处理[砂浴]在玻璃瓶中制备),含有等量的Shodhita Parada(加工汞),Shodhita Gandhaka(加工硫),Shodhita Haratala(加工三硫化砷),Shodhita Somala(加工氧化砷)和Shodhita Manahshila(加工二硫化砷)作为成分。Parada, Haratala, Manahshila和Somala是强效矿物质,由于其原始形式的毒性,被列入1940年药物和化妆品法案附表E1。材料与方法:本研究通过对charles’s寄养的白化大鼠进行慢性毒性研究,评价SPR的安全性。将待试药物用4 ml蜂蜜和7 ml蒸馏水制成悬液。试验药物口服剂量为11.25(治疗剂量[TED])、56.25(5倍TED)和112.25 mg/kg(10倍TED),每天1次,连续90天。第91天处死动物,恢复组第121天处死动物。对各脏器的血液学、血清生化、组织病理学等指标进行了研究。结果:在慢性毒性研究中,高剂量试验药物和恢复研究对白化病大鼠无毒性作用。结论:在90天的重复给药、口服、慢性毒性研究中,即使在10倍治疗当量剂量(112.25 mg/kg)和恢复期1个月时,SPR对白化病大鼠均无毒性作用。在TED上使用可能是安全的。
{"title":"Chronic toxicity study of <i>Sameera Pannaga Rasa</i> in Charle's foster albino rats.","authors":"Madhvi Sharma,&nbsp;Biswajyoti Patgiri,&nbsp;Mukesh B Nariya,&nbsp;Shrirang Jamadagni,&nbsp;Prashant Bedarkar","doi":"10.4103/ayu.AYU_49_20","DOIUrl":"https://doi.org/10.4103/ayu.AYU_49_20","url":null,"abstract":"<p><strong>Introduction: </strong><i>Sameera</i> <i>Pannaga</i> <i>Rasa</i> (SPR) is a <i>Kupi</i> <i>Pakwa</i> <i>Rasayana</i> (a mercurial-arsenical formulation of <i>Ayurveda</i> prepared by specific pharmaceutical-controlled, indirect heat treatment [sand bath] in glass bottle) that contains <i>Shodhita</i> <i>Parada</i> (processed mercury), <i>Shodhita</i> <i>Gandhaka</i> (processed sulfur), <i>Shodhita</i> <i>Haratala</i> (processed arsenic trisulfide), <i>Shodhita</i> <i>Somala</i> (processed arsenic oxide) and <i>Shodhita</i> <i>Manahshila</i> (process arsenic disulfide) in equal quantity as ingredients. <i>Parada</i>, <i>Haratala</i>, <i>Manahshila</i> and <i>Somala</i> are highly potent minerals which are included in the Drug and Cosmetic Act 1940 under Schedule E1 because of their toxic nature in crude form.</p><p><strong>Materials and methods: </strong>In the present study, SPR was evaluated for safety profile through its chronic toxicity study in Charle's foster albino rats. The test drug was made into suspension in vehicle (4 ml honey and 7 ml distilled water). The test drug was administered orally once a day for 90 consecutive days in the dose of 11.25 (therapeutic dose [TED]), 56.25 (5 times TED) and 112.25 mg/kg (10 times TED). Animals were sacrificed on 91<sup>st</sup> day and animals of recovery group were sacrificed on 121<sup>st</sup> day. Parameters such as hematological, serum biochemical, and histopathology of various organs were studied.</p><p><strong>Results: </strong>Test drug at a higher dose level and recovery study showed no toxic effect in albino rats during chronic toxicity study.</p><p><strong>Conclusion: </strong>SPR is found to have no toxic effect in albino rats during the repeated dose, oral, chronic toxicity study of 90 days, even at 10 times therapeutic equivalent dose (112.25 mg/kg) and even during recovery period of 1 month. It may be safety used at TED level.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ae/93/AYU-41-36.PMC8415237.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39473811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Is integration of various systems of medicine need of today? 各种医学系统的整合是今天的需要吗?
Ayu
Pub Date : 2020-01-01 Epub Date: 2021-07-30 DOI: 10.4103/ayu.ayu_38_21
Mandip Goyal
Upgrading health standards and contributing to promot health-care systems is the main objective of any system of medicine. Remission or cure of the disease and providing a feeling of wellbeing remain the end goal of any medical science. Science needs continuous updating and hence continuous contemplations to maintain health is among the priority areas of research. This has resulted in massive information related to human health and diseases and for these reasons today exist several schools of thought that provide opinions regarding it. Looking at the history of the civilization, it can be traced that as per the need for time and available resources, continuous efforts have been undertaken to improve and advance the health‐care system. As a consequence of it, different systems of medicine exist now in different regions of the world. Every day a new form of medicine or approach for existing diseases or newly emerging diseases are thought out and included in existing guidelines of health care after getting established by research or clinical trials. However, many of the conditions remain untreated and researchers are rigorously working to find the solutions for the same.
{"title":"Is integration of various systems of medicine need of today?","authors":"Mandip Goyal","doi":"10.4103/ayu.ayu_38_21","DOIUrl":"https://doi.org/10.4103/ayu.ayu_38_21","url":null,"abstract":"Upgrading health standards and contributing to promot health-care systems is the main objective of any system of medicine. Remission or cure of the disease and providing a feeling of wellbeing remain the end goal of any medical science. Science needs continuous updating and hence continuous contemplations to maintain health is among the priority areas of research. This has resulted in massive information related to human health and diseases and for these reasons today exist several schools of thought that provide opinions regarding it. Looking at the history of the civilization, it can be traced that as per the need for time and available resources, continuous efforts have been undertaken to improve and advance the health‐care system. As a consequence of it, different systems of medicine exist now in different regions of the world. Every day a new form of medicine or approach for existing diseases or newly emerging diseases are thought out and included in existing guidelines of health care after getting established by research or clinical trials. However, many of the conditions remain untreated and researchers are rigorously working to find the solutions for the same.","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/be/6b/AYU-41-1.PMC8415238.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39450948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A compendious review of Chitraka Haritaki Avaleha - A polyherbal Ayurveda formulation for bronchial asthma. 一个简短的回顾Chitraka Haritaki avalha -一种治疗支气管哮喘的阿育吠陀配方。
Ayu
Pub Date : 2020-01-01 Epub Date: 2021-07-30 DOI: 10.4103/ayu.AYU_340_20
Sagar Mahendrabhai Bhinde, Sonam Sagar Bhinde, Virendra K Kori, Kalpana S Patel

Introduction: Avaleha (confection) is an unique dosage form of Ayurvedic pharmaceutics, which is frequently prescribed in various disorders and especially in respiratory disorders. Chitraka Haritaki Avaleha (CHA) is one such formulation being used extensively by Ayurveda physicians for bronchial asthma, despite its classical use in various other disorders too. CHA was first time described by Vrindamadhava in the 9th century and had been amended for many times till today. Because of its demand, many pharmaceutical companies are also manufacturing it, and is freely available in the market.

Aim: The aim is to screen and compile references pertaining to composition, method of preparation, therapeutic uses, organoleptic, and physico-chemical parameters of CHA from different classics and original research articles.

Materials and methods: Description of CHA was extensively reviewed from Vrindamadhava, Chakradatta, Vangasena, Gadanigraha, Yogatarangini, Bhaishjya Ratnavali and Yogaratnakara. Synonyms, Rasapanchaka (Ayurveda principles of drug action), and Dosha Karma (therapeutic attributes) of ingredients were compiled from Bhavaprakasha Nighantu. Organoleptic and physicochemical parameters were compiled from original research articles, searched from PubMed, Google Scholar, and Research Gate.

Results: Variations in formulation name, ingredients, method of preparation, therapeutic indications and Anupana (adjuvant) was observed in the classical texts. Value of water-soluble extracts and pH of analytical study was found different than Ayurveda Pharmacopeia of India standards.

Conclusion: Screening through various texts revealed that CHA has been mentioned in seven classical treatises and two gazetted texts with amendments which indicate its high demand and clinical efficacy in bronchial asthma along with other diseases. Disparity found in analytical parameters indicates the need of standardization of pharmaceutical process.

简介:阿瓦莱哈(糖果)是一种独特的阿育吠陀药物剂型,经常用于各种疾病,特别是呼吸系统疾病。Chitraka Haritaki Avaleha (CHA)就是一种这样的配方,被阿育吠陀医生广泛用于支气管哮喘,尽管它也被用于其他各种疾病。CHA在9世纪由温达摩达瓦首次描述,并被多次修改,直到今天。由于其需求,许多制药公司也在生产它,并在市场上免费提供。目的:从不同的经典文献和原创研究文章中筛选和整理有关CHA的组成、制备方法、治疗用途、感官和理化参数等方面的文献。材料和方法:从Vrindamadhava、Chakradatta、Vangasena、Gadanigraha、Yogatarangini、Bhaishjya Ratnavali和Yogaratnakara等文献对CHA的描述进行了广泛的综述。同义词,Rasapanchaka(阿育吠陀药物作用原理)和Dosha Karma(治疗属性)成分汇编自Bhavaprakasha Nighantu。感官和物理化学参数编译自原始研究文章,检索自PubMed、Google Scholar和research Gate。结果:各经典文献在剂名、成分、制备方法、治疗指征、佐剂等方面均有差异。分析研究发现水溶性提取物的值和pH值与印度阿育吠陀药典标准不同。结论:通过各种文献筛选发现,CHA在7篇经典论著和2篇经修订的公报文献中被提及,表明其在支气管哮喘等疾病中的需求量和临床疗效。分析参数的差异表明了制药工艺标准化的必要性。
{"title":"A compendious review of <i>Chitraka Haritaki Avaleha</i> - A polyherbal <i>Ayurveda</i> formulation for bronchial asthma.","authors":"Sagar Mahendrabhai Bhinde,&nbsp;Sonam Sagar Bhinde,&nbsp;Virendra K Kori,&nbsp;Kalpana S Patel","doi":"10.4103/ayu.AYU_340_20","DOIUrl":"https://doi.org/10.4103/ayu.AYU_340_20","url":null,"abstract":"<p><strong>Introduction: </strong><i>Avaleha</i> (confection) is an unique dosage form of Ayurvedic pharmaceutics, which is frequently prescribed in various disorders and especially in respiratory disorders. <i>Chitraka</i> <i>Haritaki</i> <i>Avaleha</i> (CHA) is one such formulation being used extensively by <i>Ayurveda</i> physicians for bronchial asthma, despite its classical use in various other disorders too. CHA was first time described by Vrindamadhava in the 9<sup>th</sup> century and had been amended for many times till today. Because of its demand, many pharmaceutical companies are also manufacturing it, and is freely available in the market.</p><p><strong>Aim: </strong>The aim is to screen and compile references pertaining to composition, method of preparation, therapeutic uses, organoleptic, and physico-chemical parameters of CHA from different classics and original research articles.</p><p><strong>Materials and methods: </strong>Description of CHA was extensively reviewed from Vrindamadhava, Chakradatta, Vangasena, Gadanigraha, Yogatarangini, Bhaishjya Ratnavali and Yogaratnakara. Synonyms, <i>Rasapanchaka</i> (<i>Ayurveda</i> principles of drug action), and <i>Dosha</i> <i>Karma</i> (therapeutic attributes) of ingredients were compiled from Bhavaprakasha Nighantu. Organoleptic and physicochemical parameters were compiled from original research articles, searched from PubMed, Google Scholar, and Research Gate.</p><p><strong>Results: </strong>Variations in formulation name, ingredients, method of preparation, therapeutic indications and <i>Anupana</i> (adjuvant) was observed in the classical texts. Value of water-soluble extracts and pH of analytical study was found different than <i>Ayurveda</i> Pharmacopeia of India standards.</p><p><strong>Conclusion: </strong>Screening through various texts revealed that CHA has been mentioned in seven classical treatises and two gazetted texts with amendments which indicate its high demand and clinical efficacy in bronchial asthma along with other diseases. Disparity found in analytical parameters indicates the need of standardization of pharmaceutical process.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c0/a2/AYU-41-12.PMC8415241.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39450950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ayu
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1